Front Page
Get ready for a big year from Mika Zibanejad
The Rangers top center should flourish playing with Artemi Panarin
New York Rangers Analysis
Dive deeper with New York Rangers analysis from the Blueshirt Banter team—where strategy meets stats, trades are teased out, and every roster move gets broken down. Whether it’s youth development, roster depth, or cap-maneuvering, we give you the insight Rangers fans need.
Front Page
How the Offseason Changes the Power Play
The Rangers have some holes to fill on their power play units, let’s look at how the shiny new toys can do that.
Front Page
Rykov and Hajek and the Training Camp Battle to Come
Now that Kevin Shattenkirk is out of the picture, we are starting to get a better idea of what the New York Rangers blue line is going to look like for the 2019-20 season. The biggest subtractions — Shattenkirk and Neal Pionk — and additions — Jacob Trouba and Adam Fox — are
Front Page
Thoughts on Kevin Shattenkirk’s Buyout and What Rangers Could Have Done Differently
The New York Rangers have had a tremendous string of months since announcing their intentions to rebuild in February of 2018. Along the way they have hit a lot of the right notes, especially since being awarded the second overall pick in the draft lottery. But the soon-to-be
Front Page
Some thoughts on dead cap space
And why buyouts are best avoided at all costs
Front Page
Decision Time is Coming
Gorton and the Rangers need to find a way to get under the cap
Front Page
What the New York Rangers’ Salary Cap Situation Could Look Like After Remaining RFA Deals
The Rangers could chose to settle their RFA business before the secondary buyout window opens, and then make the necessary moves to become cap compliant.
Front Page
Initial Thoughts on Jacob Trouba’s Contract Extension
To no one’s surprise — or mostly no one’s since there are always those who are skeptical — the New York Rangers locked up Jacob Trouba to the tune of seven years and $56 million dollars ($8 million a year). And yes, I know at first blush that seems steep,
Front Page
Kaapo Kakko, Diabetes, and Celiac Disease
Kakko’s medical conditions require discipline, but they should not hold him back in any way
Front Page
Broadway Revival: Rangers Should Round Out Roster With Savvy One-Year Deals
There are a number of unsigned free agents with something to prove who would be great fits on Rangers’ roster.
Front Page
What If The New York Rangers Just Bought Out Marc Staal?
It is unlikely, but it would be a good first step in figuring out future financial landscape.
Front Page
The cap crunch
What kind of money does Gorton have to work with for the team’s four key RFAs?